(Q33805187)

29 July 2017

1 reference

title

Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists (English)

1 reference

29 July 2017

0 references

1 reference

Weisberg SC

1

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

Pediatric Pulmonology

1 reference

29 July 2017

29

1 reference

29 July 2017

1

1 reference

29 July 2017

46-61

1 reference

Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma.

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Patterns of asthma mortality in Philadelphia from 1969 to 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Changing patterns of asthma mortality. Identifying target populations at high risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Epidemiologic and socioeconomic aspects of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Differences in airway responsiveness between children and adults living in the same environment: an epidemiological study in two regions of New South Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Childhood asthma and puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

A prospective study of bronchial hyperresponsiveness and respiratory symptoms in a population of Australian schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Asthma: a disease remodeling the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Bronchial hyperresponsiveness in asthmatic children. Correlation with macrophages and eosinophils in broncholavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

21 January 2018

Steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Adverse effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Duration of growth suppressive effects of regular inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The role of leukotrienes in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Generation of leukotrienes by purified human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotrienes and airway responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Summary of clinical trials with zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Distribution of immunocompetent cells in the bronchial wall of clinically healthy subjects showing bronchial hyperresponsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Childhood asthma and allergic rhinitis: the role of leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Issues in adolescent asthma: what are the needs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Mechanism of airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Early intervention for childhood asthma: inhaled glucocorticoids as the "preferred" medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Blood Transfusion and Lung Function in Children with Thalassemia Major

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

CD4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Density of eosinophils reflects activity of disease in allergic asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Fluticasone propionate in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Validation of the Doser, a new device for monitoring metered-dose inhaler use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Adrenal effects of beclomethasone inhalation therapy in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Childhood asthma and growth--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Side effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Cromoglycate and other antiallergic drugs: a possible mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Salmeterol in the management of paediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

In vivo metabolism of leukotriene C4 in man: urinary excretion of leukotriene E4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Urinary leukotriene E4 levels during early and late asthmatic responses†

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Urinary leukotriene E after exercise challenge in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotrienes in the blood and urine of children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28200001%2929%3A1%3C46%3A%3AAID-PPUL9%3E3.0.CO%3B2-A

10.1002/(SICI)1099-0496(200001)29:1<46::AID-PPUL9>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

release_w46ihcia4bf53ftpptgahalxxi

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w46ihcia4bf53ftpptgahalxxi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10613787

1 reference

PubMed ID

10613787